Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Phronetik named one of the "20 Most Promising Pharma & Life Sciences Tech Solution Providers"By: Phronetik This award selection by a distinguished panel of CEOs, CIOs, VCs, analysts, and the CIOReview editorial board is based on Phronetik's informatics solutions that lead to advances in scientific discovery. Phronetik's informatics services consist of analyzing biological data such as genetic codes, sequencing and analysis, data abstraction, regulatory support, and adaptive research - to name a few. The company is excited to showcase its proprietary artificial intelligence platform, iConcordia™, that will assist in clinical decision making at the point-of-care. iConcordia™ is currently under development and is expected to be released in 2018. "We are thrilled to be recognized among such prestigious organizations working to improve and postively impact the pharma and life sciences industry," says Tania Martin-Mercado, Phronetik's CEO. "This award showcases our commitment to transform healthcare and improve the patient experience." About CIOReview Published from Fremont, California, CIOReview is a print magazine that explores and understands the plethora of ways adopted by firms to execute the smooth functioning of their businesses. A distinguished panel comprising of CEOs, CIOs, IT VPs including CIOReview editorial board finalized the "20 Most Promising Pharma and Life Science Technology Solution Providers 2017" in the U.S. and shortlisted the best vendors and consultants. For more info, visit http://www.cioreview.com. About Phronetik Phronetik delivers bioinformatics, health informatics, and IT services to government, hospitals, non-profits, pharmaceutical, life science, and outpatient organizations in support of clinical trials, point-of-care, public health, and healthcare operations. For more information, visit http://www.phronetik.com. For media inquiries, contant marketing@phronetik.com. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|